Last reviewed · How we verify
Deprescribing anticholinergic and sedative mediications — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Deprescribing anticholinergic and sedative mediications (Deprescribing anticholinergic and sedative mediications) — Centre de recherche du Centre hospitalier universitaire de Sherbrooke.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Deprescribing anticholinergic and sedative mediications TARGET | Deprescribing anticholinergic and sedative mediications | Centre de recherche du Centre hospitalier universitaire de Sherbrooke | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Deprescribing anticholinergic and sedative mediications CI watch — RSS
- Deprescribing anticholinergic and sedative mediications CI watch — Atom
- Deprescribing anticholinergic and sedative mediications CI watch — JSON
- Deprescribing anticholinergic and sedative mediications alone — RSS
Cite this brief
Drug Landscape (2026). Deprescribing anticholinergic and sedative mediications — Competitive Intelligence Brief. https://druglandscape.com/ci/deprescribing-anticholinergic-and-sedative-mediications. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab